Drug intelligence / Profile preview

levonordefrin

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Intranasal, Submucosal Injection
01

Overview

Levonordefrin is a synthetic sympathomimetic amine and the levoisomer of nordefrin. It is primarily used as a vasoconstrictor in local anesthetic solutions for dental procedures and as a topical nasal decongestant. Levonordefrin acts mainly by stimulating adrenergic receptors—specifically as a non-selective agonist at α1-, α2-, and β-adrenergic receptors with preferential activity at the α2-adrenergic receptor. Its pharmacologic effects are similar to those of epinephrine but it is more stable and less potent in raising blood pressure or causing vasoconstriction at equal concentrations. Levonordefrin does not cross the blood-brain barrier and its side effects are peripheral. It is rapidly metabolized by catechol-O-methyltransferase with an elimination half-life of 1–3 minutes[1][5][7].

Brand names
Neo-Cobefrine
Other names
corbadrine
02

Targets

ADRB1 (β1)ADRA1A (α1A)ADRA2A (α2A)

Beyond the preview

Go deeper on levonordefrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on levonordefrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call